Bio Techne earnings were $158.1M for the trailing 12 months ending Dec 31, 2024, with -29.1% growth year over year. The latest TECH earnings report on Dec 31, 2024 announced Q4 2024 earnings of $34.9M, up 3.8% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, TECH reported annual earnings of $168.1M, with -41.1% growth.
TECH past earnings growth
How has TECH's earnings growth performed historically?
On TECH's earnings call on Invalid Date, Bio Techne (NASDAQ: TECH) reported Q4 2024 earnings per share (EPS) of $0.22, up 29.41% year over year. Total TECH earnings for the quarter were $34.89 million. In the same quarter last year, Bio Techne's earnings per share (EPS) was $0.17.
As of the last Bio Techne earnings report, Bio Techne is currently profitable. Bio Techne's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $158.14 million, a 29.45% decrease year over year.
What was TECH's earnings growth in the past year?
As of Bio Techne's earnings date in Invalid Date, Bio Techne's earnings has grown -29.08% year over year. This is 41.22 percentage points lower than the US Biotechnology industry earnings growth rate of 12.14%. TECH earnings in the past year totalled $158.14 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.